Vetoquinol corporate brochure 2017

PRAGMATIC ORGANISATION About 150 employees are developing innovative products to meet market needs. A LONG AND EXPENSIVE PROCESS The development of a new drug requires time (on average five to ten years), the participation of multidisciplinary teams and major investments of between € 3 million and € 15 million. The process remains complex and uncertain, with just 5% of candidate projects becoming a drug in the long term. TECHNOLOGICAL INNOVATION PROGRAMME Vetoquinol has implemented a “Tech- nological Innovation” program to envision numerous paths of innova- tion for projects underway. This forg- es a firmer understanding of efficacy, tolerance and observance. The pharmaceutical technologies with highly innovative formulations devel- oped as part of this programme are applied to different galenic forms. They are applied both in products for livestock and for pets. Through these technological advances, Vetoquinol is able to meet the needs of its customers by creating new- generation drugs featuring controlled release, improved bioavailability, and the concealed taste of active ingre- dients for enhanced palatability. INNOVATION, A TEAM JOB The Business Development Divi- sion, Research and Medical Division, Product Project Division, and Product Development Division... Each pro- ject is built in close collaboration by pluridisciplinary teams and a number of departments. All of these structures belong to the Scientific Department in order to ensure internal coherence and make it possible to unlock synergies. Team work is key to the Group’s success, one of its fundamental values, and vital to its long-term future. The marketing of a drug hinges on receiving marketing authorisation (MA). Granted on the basis of an exhaustive file; MA proves that the product meets the requirements of the health authorities in terms of quality, safety and efficacy. UNE DYNAMIQUE DE CROISSANCE Vetoquinol splits its R&D projects portfolio between incremental innovation, which aims to make improvements to existing products, and disruptive innovations which lead to the creation of new technologies. 10 A CULTURE OF INNOVATION Engaged by our creativity